Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sylvamo (SLVM) Cash & Equivalents (2020 - 2025)

Historic Cash & Equivalents for Sylvamo (SLVM) over the last 6 years, with Q3 2025 value amounting to $94.0 million.

  • Sylvamo's Cash & Equivalents fell 6209.68% to $94.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $94.0 million, marking a year-over-year decrease of 6209.68%. This contributed to the annual value of $205.0 million for FY2024, which is 681.82% down from last year.
  • Sylvamo's Cash & Equivalents amounted to $94.0 million in Q3 2025, which was down 6209.68% from $113.0 million recorded in Q2 2025.
  • Sylvamo's 5-year Cash & Equivalents high stood at $360.0 million for Q4 2022, and its period low was $94.0 million during Q3 2025.
  • For the 5-year period, Sylvamo's Cash & Equivalents averaged around $181.0 million, with its median value being $163.0 million (2022).
  • Per our database at Business Quant, Sylvamo's Cash & Equivalents skyrocketed by 12641.51% in 2022 and then crashed by 6209.68% in 2025.
  • Quarter analysis of 5 years shows Sylvamo's Cash & Equivalents stood at $159.0 million in 2021, then surged by 126.42% to $360.0 million in 2022, then crashed by 38.89% to $220.0 million in 2023, then decreased by 6.82% to $205.0 million in 2024, then tumbled by 54.15% to $94.0 million in 2025.
  • Its Cash & Equivalents stands at $94.0 million for Q3 2025, versus $113.0 million for Q2 2025 and $154.0 million for Q1 2025.